China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China flag China · Delayed Price · Currency is CNY
28.36
-0.34 (-1.18%)
At close: Feb 6, 2026

SHE:000999 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
28,71226,46623,83717,41114,82513,093
Other Revenue
1,1511,151901.47667.99719.33544.28
29,86327,61724,73918,07915,54413,637
Revenue Growth (YoY)
15.43%11.63%36.84%16.31%13.98%-7.82%
Cost of Revenue
14,31213,43411,6758,3546,5615,143
Gross Profit
15,55014,18313,0649,7258,9848,494
Selling, General & Admin
10,4868,8788,4896,1355,9925,947
Research & Development
1,130801.75714.5593.94560.2459.84
Other Operating Expenses
245.98229.73262.72207.05204.39175.49
Operating Expenses
11,8919,9929,5216,9426,7706,602
Operating Income
3,6594,1913,5432,7842,2141,892
Interest Expense
-96.44-80.04-80.78-21.23-14.18-5.09
Interest & Investment Income
108.1133.9125.1118.11101.08156.22
Currency Exchange Gain (Loss)
5.485.482.5-56.25-12.89-9.68
Other Non Operating Income (Expenses)
-108.43-15.21-17.44-4.11-1.11-21.91
EBT Excluding Unusual Items
3,5684,2353,5722,8202,2872,012
Impairment of Goodwill
----65.51-44.24-174.95
Gain (Loss) on Sale of Investments
168.3668.2-28.632.585.046.87
Gain (Loss) on Sale of Assets
10.631.430.812.280.85-2.69
Asset Writedown
14.03-19.67-82.35-34.3-8.1-7.95
Other Unusual Items
278.8278.8292.43237.69202.96225.89
Pretax Income
4,0404,5943,7542,9632,4442,059
Income Tax Expense
607.3815.87580.97466.43345.41441.89
Earnings From Continuing Operations
3,4323,7783,1732,4972,0991,618
Minority Interest in Earnings
-671.44-409.85-320.55-48.21-43.49-20.04
Net Income
2,7613,3682,8532,4492,0551,597
Net Income to Common
2,7613,3682,8532,4492,0551,597
Net Income Growth
-19.04%18.05%16.50%19.16%28.65%-23.89%
Shares Outstanding (Basic)
1,6601,6651,6561,6691,6541,656
Shares Outstanding (Diluted)
1,6601,6651,6631,6691,6541,656
Shares Change (YoY)
-0.24%0.10%-0.33%0.90%-0.15%-0.07%
EPS (Basic)
1.662.021.721.471.240.96
EPS (Diluted)
1.662.021.721.471.240.96
EPS Growth
-18.85%17.94%16.89%18.10%28.83%-23.83%
Free Cash Flow
3,1303,6123,3352,0551,0121,602
Free Cash Flow Per Share
1.892.172.001.230.610.97
Dividend Per Share
0.6961.0150.8870.5920.5050.296
Dividend Growth
-57.98%14.41%49.99%17.26%70.53%16.31%
Gross Margin
52.07%51.36%52.81%53.79%57.79%62.28%
Operating Margin
12.25%15.17%14.32%15.40%14.24%13.87%
Profit Margin
9.25%12.20%11.53%13.54%13.22%11.71%
Free Cash Flow Margin
10.48%13.08%13.48%11.37%6.51%11.75%
EBITDA
4,2614,8294,2283,2512,6432,282
EBITDA Margin
14.27%17.48%17.09%17.98%17.00%16.73%
D&A For EBITDA
602.35638.08685.71467.17429.17390.19
EBIT
3,6594,1913,5432,7842,2141,892
EBIT Margin
12.25%15.17%14.32%15.40%14.24%13.87%
Effective Tax Rate
15.03%17.76%15.47%15.74%14.13%21.46%
Revenue as Reported
2,246--18,07915,54413,637
Advertising Expenses
-754.25660.33543.92578.72446.69
Source: S&P Global Market Intelligence. Standard template. Financial Sources.